Recurrent Miscarriage & Uterine Adhesions:
Is There a Connection?

You Deserve Answers. All of Them.

There is a quiet particular cruelty to recurrent pregnancy loss. Each loss arrives with the same shock as the first, except now it comes layered with dread — the knowledge of what can happen, the fear that it will happen again, the desperate hope that somehow this time will be different. And between each loss, there is the investigation: the blood draws, the genetic panels, the specialist referrals, the forums at 2 a.m. searching for the thing that nobody has found yet.

I want to say this clearly: searching for a cause is not you being "obsessive" or "unable to accept loss." It is you doing exactly what a good advocate for your own body does. And sometimes, the answer has been there the whole time — just in a part of the uterus that nobody has bothered to look at closely.

Uterine adhesions — the scar tissue at the heart of Asherman's syndrome — are one of the most overlooked causes of recurrent pregnancy loss. Women can undergo years of testing, chromosomal analysis, immunological workups, and clotting panels, and still not have had their uterine cavity directly visualised. If that's you, this article is for you.

How Uterine Adhesions Cause Miscarriage

Uterine adhesions — also called intrauterine adhesions or synechia — are bands of fibrous scar tissue that form inside the uterine cavity. They develop when the lining of the uterus (the endometrium) is damaged, most commonly after a dilation and curettage (D&C) procedure.

The endometrium is one of the most dynamic tissues in the human body. Every cycle, it thickens, becomes highly vascularised, and prepares to receive and nourish an embryo. When scar tissue replaces normal endometrial tissue, several things go wrong simultaneously:

• Implantation in inhospitable tissue. An embryo that implants on or near scar tissue cannot establish the blood supply it needs. The placenta cannot grow into healthy tissue that isn't there.
• Poor placentation. Even when a pregnancy initially takes hold, scar tissue can interfere with the deep placental invasion required for a healthy, sustained pregnancy — increasing the risk of miscarriage in the first or second trimester.
• Restricted blood flow. Adhesions physically compress the uterine cavity and can disrupt the microvasculature that feeds the developing pregnancy. Without adequate blood flow, growth falters.
• Distorted cavity shape. Bands of adhesion can bridge walls of the uterus, reducing available space and creating an abnormal environment that disrupts embryonic development.

The result can look, on the surface, like an ordinary miscarriage — a pregnancy that simply "didn't make it." Without direct inspection of the cavity, the underlying structural cause can be missed entirely.

The Diagnostic Paradox: Extensively Tested, but the Cavity Unchecked

When a woman experiences two or more miscarriages, the standard recurrent pregnancy loss (RPL) workup typically includes a significant battery of tests — antiphospholipid antibodies, Factor V Leiden, MTHFR variants, thyroid function, natural killer cell panels, chromosomal karyotyping of both partners, and sometimes genetic testing of the products of conception.

What it often does not routinely include, at least not early enough: direct hysteroscopic evaluation of the uterine cavity.

This is the hysteroscopy gap. An ultrasound or even a hysterosalpingogram (HSG) can suggest a uterine abnormality, but neither can definitively characterise or rule out intrauterine adhesions the way hysteroscopy can. The hysteroscope is the gold standard — a small camera inserted through the cervix to directly visualise the cavity in real time. Without it, adhesions of varying severity can remain undetected while a woman undergoes cycle after cycle of treatment aimed at causes that may not be present.

The Difficult Truth: Each D&C After a Loss Increases Risk

This is one of the hardest pieces of information to sit with, so I want to say it gently: the procedure most commonly used to manage a miscarriage — a dilation and curettage — is also one of the most common causes of Asherman's syndrome.

This does not mean D&C was the wrong choice. In many situations, it is medically necessary. Bleeding, infection risk, incomplete miscarriage — these are real considerations, and the doctors recommending the procedure were trying to keep you safe. But the cumulative effect of multiple uterine procedures is important to understand, particularly for women who have experienced more than one loss managed surgically.

According to the Mayo Clinic, Asherman's syndrome arises around pregnancy with trauma or insult to the gravid uterus, and predisposing factors include instrumentation of the uterus — including D&C for bleeding or retained placenta. The highest risk period appears to be postpartum, following any pregnancy loss, including first and second trimester miscarriage.

If you have had multiple D&C procedures across multiple losses, and you have not been screened for adhesions, the connection is worth exploring with urgency and without guilt.

Thin Lining + Recurrent Loss: The Silent Signal

One of the more consistent findings in women with Asherman's-related pregnancy loss is a persistently thin endometrial lining. A lining below approximately 7mm at the time of implantation is associated with significantly reduced pregnancy rates and higher miscarriage risk — and thin lining is often a direct consequence of adhesion-related endometrial damage.

If you have been told your lining is "thin" during IVF or fertility treatment cycles, if your periods have become lighter or shorter since a D&C, or if you have experienced spotting rather than full flow — these are potential indicators of endometrial compromise that deserve investigation beyond a standard ultrasound measurement.

Thin lining is not simply a number problem. It reflects the health of the tissue itself — whether it is receptive, well-vascularised, and capable of supporting an early pregnancy. Treating the number without investigating the cause is treating the symptom without addressing the source.

What the Research Says About Treatment and Outcomes

A prospective study published in the National Library of Medicine (PMC4819213) followed 60 patients diagnosed with Asherman's syndrome on hysteroscopy, evaluating the effect of hysteroscopic adhesiolysis on menstrual and reproductive outcomes.

The study also found that pregnancy rates were significantly associated with adhesion severity and post-operative endometrial status — with women who achieved normal uterine echoes after adhesiolysis reaching pregnancy rates of 54.5%, compared to 10.5% in those with persistently altered endometrial findings. This reinforces the importance of not only treating adhesions, but of ensuring the endometrium has genuinely recovered before attempting pregnancy.

Critically, this research demonstrates that treatment does make a meaningful difference. Hysteroscopic adhesiolysis is not a guarantee — outcomes vary depending on the extent of the adhesions, the skill of the surgeon, the health of the remaining endometrium, and whether repeat procedures are needed. But for many women with undiagnosed Asherman's, getting the right diagnosis and the right treatment has been the turning point after years of unexplained loss.

Questions to Ask Your Recurrent Pregnancy Loss Specialist

Walking into a specialist appointment after multiple losses can feel overwhelming. Having specific questions prepared can help you ensure that uterine factors are fully evaluated — not just gestured at. Here are questions worth raising:

• Has my uterine cavity been directly visualised by hysteroscopy, or only by ultrasound or HSG?
• Given my history of D&C procedures, should we consider a diagnostic hysteroscopy before the next treatment cycle?
• What is my endometrial thickness in my natural cycles, and is it consistent?
• Could intrauterine adhesions explain my pregnancy losses even if my periods seem relatively normal?
• If adhesions are found, who at this clinic has specific experience in hysteroscopic adhesiolysis, and how many of these procedures have they performed?
• If adhesiolysis is done, what post-operative protocol will be used to prevent re-adhesion and support endometrial recovery?
• How will we evaluate endometrial recovery before attempting a subsequent pregnancy?

You are not being difficult by asking these questions. You are being an informed advocate for yourself — and that advocacy is exactly what the situation requires.

Emotional Recovery Matters Just as Much as Physical Recovery

There is a tendency in medicine — and perhaps in all of us when we are frightened — to focus entirely on the physical: the test results, the procedures, the waiting. But the emotional toll of recurrent pregnancy loss is real, significant, and medically relevant. Chronic grief and anxiety affect cortisol, sleep, and immune function. They affect how clearly you can think in a consultation room, how well you can advocate for yourself, and how much bandwidth you have to absorb complex information.

Giving yourself permission to grieve — properly, without a timeline — is not separate from the work of finding answers. It is part of it. Finding a counsellor experienced in pregnancy loss, connecting with a community of women who have been through this (The Asherman's Compass community includes many of them), and building in genuine rest are not luxuries. They are part of the recovery that makes everything else possible.

You are not just treating a uterus. You are healing a whole person who has been through something profound.

A Note on Hope

I want to be careful here, because I know that hope can feel dangerous when it has been disappointed before. So I will say this in the most grounded way I can: treatment for Asherman's syndrome does help many women go on to have successful pregnancies. Not all. Not without effort and sometimes multiple procedures. But meaningfully, substantially, many.

The research cited above found live birth rates of 38.5% in women with mild adhesions — in a cohort where many had been struggling for an average of over nine years. Women with normal post-operative endometrial findings achieved live birth rates above 40%. These are not trivial numbers for a population that had largely been written off as unexplained.

The path is not always linear. There may be repeat procedures, careful monitoring, assisted reproduction. But finding the right diagnosis — after years of searching — is often described by the women I hear from as the first time they felt like something was finally being done, not just endured.

If Asherman's is part of your story, you deserve that same clarity.

Already have the Guide? The Recovery Tracker — $4.99/mo — helps you log symptoms, track your lining, and prepare for appointments with data in hand.